4//SEC Filing
SUPERNUS PHARMACEUTICALS INC 4
Accession 0001104659-15-023152
$SUPNCIK 0001356576operating
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 5:33 PM ET
Size
12.1 KB
Accession
0001104659-15-023152
Insider Transaction Report
Form 4
Bryan Jones W.
VP of Business Development
Transactions
- Exercise/Conversion
Common Stock
2015-03-24$2.56/sh+25$64→ 69,880 total - Exercise/Conversion
Common Stock
2015-03-24$3.36/sh+1,875$6,300→ 69,855 total - Sale
Common Stock
2015-03-24$12.00/sh−1,900$22,800→ 67,980 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-24−1,875→ 625 totalExercise: $3.36Exp: 2020-02-10→ Common Stock (1,875 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-24−25→ 37,475 totalExercise: $2.56Exp: 2020-11-02→ Common Stock (25 underlying)
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan adopted on April 21, 2014.
- [F2]The option vested in four equal annual installments beginning on February 10, 2011.
- [F3]The option vested in four equal annual installments beginning on November 2, 2011.
Documents
Issuer
SUPERNUS PHARMACEUTICALS INC
CIK 0001356576
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356576
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 5:33 PM ET
- Size
- 12.1 KB